IL1B and tuberculosis: While aerobic glycolysis and increased IL-1β initially promotes control of bacterial replication [26], our findings suggest that as TB disease progresses in humans, TCA cycle remodeling increases arachidonic acid metabolism and conversion to proinflammatory eicosanoids, potentially worsening tissue damage and increasing disease severity.